Transcranial Magnetic Stimulation Therapy (TMS) at StonyCreek

StonyCreek is a licensed NeuroStar Provider

NeuroStar uses transcranial magnetic stimulation (TMS) to target key areas of the brain that are underactive in people with depression. It is not ECT (electroconvulsive therapy). While the exact cause of depression is not known, the leading scientific theory is that it is caused by an imbalance of the brain’s neurotransmitters, which are chemical messengers that send signals between brain cells.

Woman reclining in a modern medical device for brain treatment.

What is NeuroStar Advanced Therapy (TMS)?

Magnets similar in strength to that used in a magnetic resonance imaging (MRI) machine is used to stimulate nerve cells in the area of the brain thought to control mood.

These magnetic pulses may have a positive effect on the brain’s neurotransmitter levels, making long-term remission possible.

NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and older.

Treatment with NeuroStar Advanced Therapy is easy:

Therapy sessions are conducted in your NeuroStar doctor’s office.

You can return to normal activities right away.

You are awake during treatment.

There are no negative effects on memory or sleep.

It’s covered by most health insurance plans.

How It Works

Before Treatment

You’ll recline comfortably in the treatment chair. A small, curved magnetic coil will be positioned lightly on your head.

During Treatment

NeuroStar delivers focused magnetic stimulation directly to the target areas of the brain. You’ll hear a clicking sound and feel a tapping sensation on your head.

In-office treatment with NeuroStar TMS Therapy typically takes 19-37 minutes and is administered 5 days a week for approximately 6-7 weeks.

After Treatment

Depending on your doctor’s recommendation, each treatment takes between 19 and 37 minutes. You can resume normal activities immediately. Because there are no effects on alertness or memory, you can drive yourself to and from treatment sessions.

In-office treatment with NeuroStar TMS Therapy typically takes 19-37 minutes and is administered 5 days a week for approximately 4-6 weeks.*

Meet Your TMS Care Team

Frequently Asked Questions

Transcranial magnetic stimulation, often referred to as TMS is a noninvasive procedure that uses magnetic fields to stimulate nerve cells in the brain to improve symptoms of depression. TMS is typically used when antidepressant medications haven’t been effective, have ceased working, or as an alternative to medication.

Your full treatment session will last 19 minutes. The tapping will continue throughout that time. You’ll be fully awake and alert during the treatment.

You’ll be able to resume normal activities immediately after your treatment. NeuroStar does not have the same systemic side effects as medications.

Most major insurances accepted!

Real Patients. Real Results

Explore NeuroStar TMS Success Stories

Adult Indications for Use
The NeuroStar Advanced Therapy System is indicated for the treatment of depressive episodes and for decreasing anxiety symptoms for those who may exhibit comorbid anxiety symptoms in adult patients suffering from Major Depressive Disorder (MDD) and who failed to achieve satisfactory improvement from previous antidepressant medication treatment in the current episode. The NeuroStar Advanced Therapy System is intended to be used as an adjunct for the treatment of adult patients suffering from Obsessive Compulsive Disorder (OCD).

Adolescent Indications for Use
NeuroStar Advanced Therapy is indicated as an adjunct for the treatment of Major Depressive Disorder (MDD) in adolescent patients (15-21).

Important Safety Information
NeuroStar Advanced Therapy is only available by prescription. A doctor can help decide if NeuroStar Advanced Therapy is right for you. Patients’ results may vary. The most common side effect is pain or discomfort at or near the treatment site. These events are transient; they occur during the TMS treatment course and do not occur for most patients after the first week of treatment. There is a rare risk of seizure associated with the use of TMS therapy (<0.1% per patient). Visit neurostar.com for full safety and prescribing information.